Healthcare (Commonwealth Union) – Type 1 diabetes is less common when compared to type 2 diabetes. It is an autoimmune condition not linked to lifestyle and can have serious consequences without treatment. Teplizumab has been approved by the National Institute for Health and Care Excellence (NICE), following its earlier use under an early access scheme [...]